Clovis Oncology
is a Colorado-based pharmaceutical company that provides oral molecule drugs that focus on acquiring, developing, and commercializing cancer treatments... Read moreClovis Oncology
is a Colorado-based pharmaceutical company that provides oral molecule drugs that focus on acquiring, developing, and commercializing cancer treatments... Read more
CEO
Add
2009
PrivateFiled for Bankruptcy
News
Jul 11, 2023
MarketScreener
Clovis Oncology: Clovis Oncology : D.I. 616, 823, 848, 884 - Form 8-K
Jun 30, 2023
MarketScreener
Clovis Oncology: Clovis Oncology : Modification to Rights of Security Holders - Form 8-K
May 03, 2023
MarketScreener
Clovis Oncology: Clovis Oncology : UNITED STATES BANKRUPTCY COURT - Form 8-K
Apr 14, 2023
MarketScreener
Clovis Oncology: Clovis Oncology : Acquisition/Asset Disposal - Form 8-K
Apr 07, 2023
BioPharma Dive
Clovis Oncology: Navigating bankruptcy, Clovis reaches deal to sell cancer drug Rubraca
Feb 13, 2023
MarketScreener
Clovis Oncology: Clovis Oncology : Regulation FD Presentation - Form 8-K
Dec 29, 2022
BizWest
Clovis Oncology: Clovis files to abandon leases in California
Dec 22, 2022
Global Legal Chronicle
Clovis Oncology: Clovis Oncology's Chapter 11 Proceeding and Asset Sale
Dec 13, 2022
News Brig
Clovis Oncology: Clovis Enters Bankruptcy With Deal to Sell Cancer-Drug Candidate to Novartis
Dec 13, 2022
BizWest
Clovis Oncology: Bankrupt Clovis faces delisting from Nasdaq
Clovis Oncology Competitors
1
2
3
4
5
6
7
8
9
10